Lista de obras - E Richard Gold - Dominio Público Uruguay

A model of regulatory burden in technology diffusion: The case of plant-derived vaccines

article

AMP v. Myriad: A Surgical Strike on Blockbuster Business Models

artículo científico publicado en 2013

Accelerating Translational Research through Open Science: The Neuro Experiment

artículo científico publicado en 2016

An Open Toolkit for Tracking Open Science Partnership Implementation and Impact

An open toolkit for tracking open science partnership implementation and impact

artículo científico publicado en 2019

An open toolkit for tracking open science partnership implementation and impact.

artículo científico publicado en 2019

Are patents impeding medical care and innovation?

artículo científico publicado en 2010

Avoiding the Mistakes of Biotech: How Intellectual Property Can Be Better Managed to Advance Nanotechnology Research

scholarly article by E Richard Gold published 26 January 2010 in Studies in Ethics, Law, and Technology

Biotechnology patents: strategies for meeting economic and ethical concerns

scholarly article by E Richard Gold et al published April 2002 in Nature Genetics

Cell therapy licensing: a web for the unwary in Kimble v. Marvel Entertainment?

artículo científico publicado en 2016

Consensus-seeking, distrust and rhetorical entrapment: The WTO decision on access to medicines

DNA patents and diagnostics: not a pretty picture

artículo científico publicado en 2010

Defining Success in Open Science

artículo científico publicado en 2018

Defining Success in Open Science

Does intellectual property lead to economic growth? Insights from a novel IP dataset

Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translation

artículo científico publicado en 2012

Finding common cause in the patent debate

article

Gene patents still alive and kicking: their impact on provision of genetic testing for long QT syndrome in the Canadian public health-care system ⬇️

artículo científico publicado en 2017

Gene patents—more evidence needed, but policymakers must act

article

Genetic Resources and Traditional Knowledge

article

Genetic technologies, health care policy and the patent bargain

article

Genetic testing, ethical concerns, and the role of patent law

Genomics knowledge and equity: a global public goods perspective of the patent system

artículo científico publicado en 2004

Identifying the challenges in implementing open science

International socialization at the state and individual levels: mixed evidence from intellectual property

article

More Haste, Less Speed: Could Public-Private Partnerships Advance Cellular Immunotherapies?

artículo científico publicado en 2017

Motivating participation in open science by examining researcher incentives

artículo científico publicado en 2017

Moving the gene patent debate forward.

artículo científico publicado en 2000

Myriad Genetics: In the eye of the policy storm

artículo científico publicado en 2010

Needed: models of biotechnology intellectual property

scientific article published on 01 August 2002

Patent landscape analysis: A methodology in need of harmonized standards of disclosure

article

Patent landscaping for life sciences innovation: toward consistent and transparent practices

artículo científico publicado en 2013

Patenting human genetic material: refocusing the debate

artículo científico publicado en 2000

Patents and Human Rights: A Heterodox Analysis

Promising Trends in Access to Medicines

artículo científico publicado en 2012

Recalibrating intellectual property rights to enhance translational research collaborations

artículo científico publicado en 2012

SARS genome patent: symptom or disease?

artículo científico publicado en 2003

The European Biotech Directive: Past as Prologue

article

The Monsanto decision: The edge or the wedge

The missing ingredient in medicine patent pools

artículo científico publicado en 2009

The moral tollbooth: a method that makes use of the patent system to address ethical concerns in biotechnology

artículo científico publicado en 2002

What the COVID-19 pandemic revealed about intellectual property

artículo científico publicado en 2022

Lista de obras de E Richard Gold

A model of regulatory burden in technology diffusion: The case of plant-derived vaccines

AMP v. Myriad: A Surgical Strike on Blockbuster Business Models

Accelerating Translational Research through Open Science: The Neuro Experiment

An Open Toolkit for Tracking Open Science Partnership Implementation and Impact

An open toolkit for tracking open science partnership implementation and impact

An open toolkit for tracking open science partnership implementation and impact.

Are patents impeding medical care and innovation?

Avoiding the Mistakes of Biotech: How Intellectual Property Can Be Better Managed to Advance Nanotechnology Research

Biotechnology patents: strategies for meeting economic and ethical concerns

Cell therapy licensing: a web for the unwary in Kimble v. Marvel Entertainment?

Consensus-seeking, distrust and rhetorical entrapment: The WTO decision on access to medicines

DNA patents and diagnostics: not a pretty picture

Defining Success in Open Science

Defining Success in Open Science

Does intellectual property lead to economic growth? Insights from a novel IP dataset

Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translation

Finding common cause in the patent debate

Gene patents still alive and kicking: their impact on provision of genetic testing for long QT syndrome in the Canadian public health-care system ⬇️

Gene patents—more evidence needed, but policymakers must act

Genetic Resources and Traditional Knowledge

Genetic technologies, health care policy and the patent bargain

Genetic testing, ethical concerns, and the role of patent law

Genomics knowledge and equity: a global public goods perspective of the patent system

Identifying the challenges in implementing open science

International socialization at the state and individual levels: mixed evidence from intellectual property

More Haste, Less Speed: Could Public-Private Partnerships Advance Cellular Immunotherapies?

Motivating participation in open science by examining researcher incentives

Moving the gene patent debate forward.

Myriad Genetics: In the eye of the policy storm

Needed: models of biotechnology intellectual property

Patent landscape analysis: A methodology in need of harmonized standards of disclosure

Patent landscaping for life sciences innovation: toward consistent and transparent practices

Patenting human genetic material: refocusing the debate

Patents and Human Rights: A Heterodox Analysis

Promising Trends in Access to Medicines

Recalibrating intellectual property rights to enhance translational research collaborations

SARS genome patent: symptom or disease?

The European Biotech Directive: Past as Prologue

The Monsanto decision: The edge or the wedge

The missing ingredient in medicine patent pools

The moral tollbooth: a method that makes use of the patent system to address ethical concerns in biotechnology

What the COVID-19 pandemic revealed about intellectual property